Proactive Investors - Run By Investors For Investors

BioTime spins out its early-stage technology into new company

BioTime Inc (NYSEAMERICAN:BTX) CEO Brian Culley sat down with Proactive Investors at the 11th Annual LD Micro Main Event in Los Angeles. 

BioTime specializes in regenerative medicine and utilizes advances in stem cell biology, biomaterials, lab-generated cells and tissues, and biologics to engineer and provide healthy cells, tissues and organs to patients with chronic degenerative diseases.

Culley says BioTime has taken some its early stage technology from the company and packaged as a standalone and spun-out as a company called AgeX Therapeutics Inc (NYSEAMERICAN:AGE).

Meet ICOx Innovations at our event, New York , 30 January 2019. Register here »
View full BTX profile View Profile

BioTime Timeline

Copyright ©, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use